Literature DB >> 14525606

Old-for-old kidney allocation allows successful expansion of the donor and recipient pool.

Lutz Fritsche1, Jan Hörstrup, Klemens Budde, Petra Reinke, Markus Giessing, Stefan Tullius, Stefan Loening, Peter Neuhaus, Hans-Hellmut Neumayer, Ulrich Frei.   

Abstract

Allocation of kidneys from donors older than 64 years to recipients older than 64 years was started in 1999 to improve use of older donor kidneys. Kidneys are allocated locally without HLA-matching to keep cold ischemia short. We compared survival and rejection rates in elderly patients allocated in the old-for-old program (ESP) to patients aged 60 years and older based on HLA-matching, expected ischemia and waiting time (ETKAS). The 69 ESP patients were older (67.9 +/- 2.5 vs. 63.9 +/- 2.9 years), had older donors (71.2 +/- 3.9 vs. 44.6 +/- 14.5 years) and more HLA-mismatches (4.2 +/- 1.2 vs. 1.6 +/- 1.7) than the 71 ETKAS patients, while ischemia was shorter (7.8 +/- 3.4 vs. 14.2 +/- 5.5 h). ESP and ETKAS had similar graft (1-year: 83.6% vs. 86.9%) and patient survival (85.2% vs. 89.5%). With the introduction of ESP, use of older recipients and donors rose from less than 2% to 16% and 11%, respectively. Incidence of acute rejections was significantly higher in the ESP group (1 year: 43.2% vs. 27.4%) and significantly correlated with the degree of HLA-matching. Introduction of old-for-old allocation allows successful expansion of the donor and recipient pool without affecting patient and graft survival. HLA-matching should not be ignored, as the risk of acute rejection in elderly patients is substantial.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14525606     DOI: 10.1046/j.1600-6135.2003.00251.x

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  21 in total

1.  Utility and safety of early allograft biopsy in adult deceased donor kidney transplant recipients.

Authors:  Evaldo Favi; Ajith James; Carmelo Puliatti; Phil Whatling; Mariano Ferraresso; Chiara Rui; Roberto Cacciola
Journal:  Clin Exp Nephrol       Date:  2019-11-25       Impact factor: 2.801

Review 2.  Canadian Society of Transplantation: consensus guidelines on eligibility for kidney transplantation.

Authors:  Greg Knoll; Sandra Cockfield; Tom Blydt-Hansen; Dana Baran; Bryce Kiberd; David Landsberg; David Rush; Edward Cole
Journal:  CMAJ       Date:  2005-11-08       Impact factor: 8.262

3.  Pathology: donor biopsy evaluation at time of renal grafting.

Authors:  Volker Nickeleit
Journal:  Nat Rev Nephrol       Date:  2009-05       Impact factor: 28.314

Review 4.  Immunosenescence in renal transplantation: a changing balance of innate and adaptive immunity.

Authors:  Midas Seyda; Markus Quante; Hirofumi Uehara; Bendix R Slegtenhorst; Abdala Elkhal; Stefan G Tullius
Journal:  Curr Opin Organ Transplant       Date:  2015-08       Impact factor: 2.640

Review 5.  Strategies for an Expanded Use of Kidneys From Elderly Donors.

Authors:  María José Pérez-Sáez; Núria Montero; Dolores Redondo-Pachón; Marta Crespo; Julio Pascual
Journal:  Transplantation       Date:  2017-04       Impact factor: 4.939

6.  Outcomes of transplanting deceased-donor kidneys between elderly donors and recipients.

Authors:  Markus Giessing; T Florian Fuller; Frank Friedersdorff; Serdar Deger; Andreas Wille; Hans-Hellmut Neumayer; Danilo Schmidt; Klemens Budde; Lutz Liefeldt
Journal:  J Am Soc Nephrol       Date:  2008-12-10       Impact factor: 10.121

7.  [Kidney donors and kidney transplantation in the elderly].

Authors:  M Giessing; S Conrad; B Schönberger; H Huland; K Budde; H-H Neumayer; S A Loening
Journal:  Urologe A       Date:  2004-08       Impact factor: 0.639

8.  Prolonged graft survival in older recipient mice is determined by impaired effector T-cell but intact regulatory T-cell responses.

Authors:  Christian Denecke; Damanpreet Singh Bedi; Xupeng Ge; Irene Kyung-Eun Kim; Anke Jurisch; Anne Weiland; Antje Habicht; Xian C Li; Stefan G Tullius
Journal:  PLoS One       Date:  2010-02-16       Impact factor: 3.240

9.  Increased incidence of angioedema with ACE inhibitors in combination with mTOR inhibitors in kidney transplant recipients.

Authors:  Michael Duerr; Petra Glander; Fritz Diekmann; Duska Dragun; Hans-H Neumayer; Klemens Budde
Journal:  Clin J Am Soc Nephrol       Date:  2010-01-21       Impact factor: 8.237

10.  Benefit of kidney transplantation beyond 70 years of age.

Authors:  Kristian Heldal; Anders Hartmann; Diana C Grootendorst; Dinanda J de Jager; Torbjørn Leivestad; Aksel Foss; Karsten Midtvedt
Journal:  Nephrol Dial Transplant       Date:  2009-12-27       Impact factor: 5.992

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.